Simple urine test may spare bladder cancer patients from unnecessary treatments
NCT ID NCT07252297
First seen Jan 05, 2026 · Last updated May 12, 2026 · Updated 21 times
Summary
This study looks at whether a urine test measuring SIX6 gene methylation can predict if low-risk bladder cancer will come back after surgery. Researchers will compare test results from 177 patients who had a recurrence versus those who did not. If accurate, this test could help doctors avoid overtreating patients with unnecessary long-term therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON MUSCLE INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xi Jing Hopspital
Xi'an, ShannxI, 710300, China
Conditions
Explore the condition pages connected to this study.